FDA Drug Application (021014) for TRILEPTAL by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number021014
Product Number001
FormTABLET;ORAL
Dosage150MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTRILEPTAL
Active IngredientOXCARBAZEPINE

Active IngredientCount
List of drugs with Active Ingredient OXCARBAZEPINE3


Back to FDA Applications sponsored by NOVARTIS